Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Glenn Insider Profile
4 Followers
Scott Glenn, Director at Evoke Pharma, holds 40.85K shares in Evoke Pharma (Ticker: EVOK), holds 476.56K shares in Dexcom (Ticker: DXCM), holds 143.85K shares in Santarus (Ticker: SNTS).
Scott Glenn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Scott Glenn
Scott Glenn's Trading History
Evoke Pharma
Oct 02, 2013
Director
Uninformative Buy
―
$18.83K
Dexcom
―
Ten Percent Owner
―
$60.55M
Santarus
―
―
―
―
Somaxon Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Scott Glenn's performance on stock
You May Also Like
Scott Glenn insider profile FAQ
What is the percentage of profitable transactions made by Scott Glenn?
The percentage of profitable transactions made by Scott Glenn is ―.
What is the average return per transaction made by Scott Glenn?
The average return per transaction made by Scott Glenn is ―.
What stocks does Scott Glenn hold?
Scott Glenn holds: EVOK, DXCM, SNTS, SOMX stocks.
What was Scott Glenn’s latest transaction?
Scott Glenn latest transaction was an Uninformative Buy of ―.
What was Scott Glenn's most profitable transaction?
Scott Glenn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Scott Glenn's role in Evoke Pharma?
Scott Glenn's role in Evoke Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.